|
| Health and medical information for consumers, quality assured by the Victorian government (Australia). |
|
 |
|
|
|
     |
|
|
|
 |
More information
Further information related to this fact sheet:
Rheumatoid arthritis.
|
|
| |
Related information on Better Health Channel
Arthritis.
Arthritis - juvenile.
Arthritis and diet.
Arthritis and exercise.
Arthritis and water exercise.
Bursitis.
Gout.
Hip disorders.
Immune system.
Knee replacement surgery.
|
Related information on other websites
Arthritis Victoria.
|
Australian Rheumatology Association.
Therapeutic Goods Administration
|
Support groups
Arthritis Victoria.
|
References used for this fact sheet
- Rheumatoid arthritis [online], Arthritis Victoria. More information here.
- Managing your condition [online], Arthritis Victoria. More information here.
- Medicines and arthritis [online], Arthritis Victoria. More information here.
- Medicine Information Sheets [online], Australian Rheumatology Association. More information here.
- ‘Rofecoxib, celecoxib and cardiovascular risk’ [online], in Australian Adverse Drug Reactions Bulletin, vol. 22, no. 5, October 2003, Therapeutic Goods Administration. More information here.
- Urgent advice regarding management of patients taking lumiracoxib (Prexige) [online], Therapeutic Goods Administration, Australia. More information here.
|
|
|
| |
Last updated: February 2009
Quality assurance
This fact sheet, like all fact sheets on the Better Health Channel, has passed through a rigorous and exhaustive approval process. It is also regularly updated. For more information see our quality assurance page.
|
|
|
